|
MYLIP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.591000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.596200E-03 |
| Normal-vs-Stage2 |
2.512200E-01 |
| Normal-vs-Stage3 |
3.75500000000528E-05 |
| Normal-vs-Stage4 |
5.73050000007846E-07 |
| Stage1-vs-Stage2 |
2.682600E-01 |
| Stage1-vs-Stage3 |
1.385580E-02 |
| Stage1-vs-Stage4 |
1.577850E-04 |
| Stage2-vs-Stage3 |
9.842700E-03 |
| Stage2-vs-Stage4 |
9.162800E-04 |
| Stage3-vs-Stage4 |
1.782380E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.190000E-04 |
| Normal-vs-AfricanAmerican |
2.489800E-02 |
| Normal-vs-Asian |
4.616100E-02 |
| Caucasian-vs-AfricanAmerican |
8.848000E-01 |
| Caucasian-vs-Asian |
2.924600E-01 |
| AfricanAmerican-vs-Asian |
3.944200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.304000E-02 |
| Normal-vs-Female |
1.561560E-04 |
| Male-vs-Female |
2.275600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.214310E-02 |
| Normal-vs-Age(41-60Yrs) |
1.884330E-03 |
| Normal-vs-Age(61-80Yrs) |
6.33660000000091E-05 |
| Normal-vs-Age(81-100Yrs) |
1.558070E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.943400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.755900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.476950E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.716020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.412400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.658400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.0920153670213E-12 |
| Classical-VS-Follicular |
4.696200E-01 |
| Classical-VS-Other |
4.872000E-01 |
| Classical-VS-Normal |
5.799100E-03 |
| Tall-VS-Follicular |
5.24200000073805E-08 |
| Tall-VS-Other |
4.945900E-02 |
| Tall-VS-Normal |
2.34500197038301E-11 |
| Follicular-VS-Other |
3.698600E-01 |
| Follicular-VS-Normal |
4.683700E-03 |
| Other-VS-Normal |
6.879600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.023700E-03 |
| Normal-vs-N1 |
4.64050000004157E-06 |
| N0-vs-N1 |
3.923700E-03 |
|
|
